Varian (NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting (PTCOG) in Manchester, United Kingdom
PALO ALTO, Calif., June 7, 2019 /PRNewswire/ -- Varian,(NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting (PTCOG) in Manchester, United Kingdom. The FlashForward Consortium’s mission is to continue research and build an evidence-based introduction of FLASH Therapy using the ProBeam® platform. In addition to the FlashForward Consortium meeting, Varian will be hosting a lunch symposium, one oral presentation and two ePosters on FLASH Therapy at PTCOG58: Varian Lunch Symposium: “FLASH Therapy: A Potential Paradigm Shift in Cancer Treatment” Manchester Central, Exchange Auditorium Oral Presentation: Planning and Delivery of FLASH in a clinical ProBeam: a preclinical study: by Eric Abel on Saturday, June 15th, 10:30am-12:00pm at the Exchange Auditorium ePosters: FLASH Radiotherapy: A look at ultra-high dose rate research and treatment plans: by Anthony Magliari and Jessica Perez Proton beam diagnostics for ultra-high dose rate irradiations: by Simon Busold and Juergen Heese FLASH Therapy is a non-invasive treatment using an external beam delivered in high doses, at ultra-high speeds (less than 1 second), and in one to three treatments. It represents an exciting and potentially promising new direction in the treatment of cancer. About Varian Press Contact Mark Plungy Investor Relations Contact J. Michael Bruff
SOURCE Varian | ||
Company Codes: NYSE:VAR |